OMIC

Singular Genomics Systems Inc

LABORATORY ANALYTICAL INSTRUMENTS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Singular Genomics Systems Inc Stock Price

Vitals

Today's Low:
$2.4800
Today's High:
$2.7400
Open Price:
$2.6600
52W Low:
$2.15
52W High:
$17.77
Prev. Close:
$2.6200
Volume:
121106

Company Statistics

Market Cap.:
$0.177 billion
Book Value:
4.187
Revenue TTM:
$0.000 billion
Operating Margin TTM:
0%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
0%
Return on Assets TTM:
-13.9%
Return on Equity TTM:
-25.1%

Company Profile

Singular Genomics Systems Inc had its IPO on 2021-05-27 under the ticker symbol OMIC.

The company operates in the LIFE SCIENCES sector and LABORATORY ANALYTICAL INSTRUMENTS industry. Singular Genomics Systems Inc has a staff strength of 0 employees.

Stock update

Shares of Singular Genomics Systems Inc opened at $2.66 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $2.48 - $2.74, and closed at $2.49.

This is a -4.96% slip from the previous day's closing price.

A total volume of 121,106 shares were traded at the close of the day’s session.

In the last one week, shares of Singular Genomics Systems Inc have increased by +24.5%.

Singular Genomics Systems Inc's Key Ratios

Singular Genomics Systems Inc has a market cap of $0.177 billion, indicating a price to book ratio of 0.636 and a price to sales ratio of -.

In the last 12-months Singular Genomics Systems Inc’s revenue was $0.000 billion with a gross profit of $0.000 billion and an EBITDA of $-0.082 billion. The EBITDA ratio measures Singular Genomics Systems Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Singular Genomics Systems Inc’s operating margin was 0% while its return on assets stood at -13.9% with a return of equity of -25.1%.

In Q2, Singular Genomics Systems Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Singular Genomics Systems Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
31.13
PEG
None

Its diluted EPS in the last 12-months stands at $0.08 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Singular Genomics Systems Inc’s profitability.

Singular Genomics Systems Inc stock is trading at a EV to sales ratio of - and a EV to EBITDA ratio of 0.485. Its price to sales ratio in the trailing 12-months stood at -.

Singular Genomics Systems Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Singular Genomics Systems Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Singular Genomics Systems Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Singular Genomics Systems Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Singular Genomics Systems Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Singular Genomics Systems Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$2.49
52-Week High
$17.77
52-Week Low
$2.15
Analyst Target Price
$3.67

Singular Genomics Systems Inc stock is currently trading at $2.49 per share. It touched a 52-week high of $17.77 and a 52-week low of $17.77. Analysts tracking the stock have a 12-month average target price of $3.67.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Singular Genomics Systems Inc

The stock symbol (also called stock or share ticker) of Singular Genomics Systems Inc is OMIC

The IPO of Singular Genomics Systems Inc took place on 2021-05-27

Similar Industry Stocks (LABORATORY ANALYTICAL INSTRUMENTS)

Last Price
Chg
Chg%
Illumina Inc (ILMN)
$210.98
-8.15
-3.72%
$8.08
-0.73
-8.29%
$26.92
-1.3
-4.61%
$2.23
-0.15
-6.3%
$10.25
-0.93
-8.32%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Singular Genomics Systems, Inc., a life sciences technology company, develops next-generation sequencing and multiomics technology to build products for researchers and clinicians for the advancement of science and medicine. The company is headquartered in La Jolla, California.

Address

10931 N. TORREY PINES ROAD, SUITE #100, LA JOLLA, CA, US